Quantitative Resting Myocardial Blood Flow Comparison by Cardiac MRI and PET

Overview

About this study

The purpose of this study is to evaluate the diagnostic performance of quantitative MBF technique by MRI in patients with cardiomyopathy and to determine the correlation with the current clinical standard of 13N-ammonia PET.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults equal or greater than 18 years of age.
  • Subjects who have a clinically scheduled cardiac MRI without and with contrast study within 13 months from a clinically scheduled or performed 13N-ammonia PET-CT study.

Exclusion Criteria:  

  • Unable to consent or unable to complete the clinical MRI and PET-CT.
  • Presence of implantable cardiac pacemaker, defibrillator or recorder.
  • Significant artifact from prior MRI studies.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 9/26/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ian Chang, M.D.

Contact us for the latest status

Contact information:

Ian Chang M.D.

(507) 293-3800

Chang.Ian@mayo.edu

More information

Publications

Publications are currently not available